Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04131829 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

StatusRecruiting
PhasePhase 1/2
Started2019-10-14
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 14 months later Jun 30, 2026 → Sep 2027
See other at-risk trials from Yale University

Amendment history

2026-09-23
Primary completion pushed: 2026-06-30 → 2027-09
Completion pushed: 2026-12-31 → 2027-09
2025-08-12
Study Status v10
Primary completion date2025-06-30→2026-06-30
Completion date2025-12-31→2026-12-31
2024-10-03
Study Status v9
Primary completion date2024-07-31→2025-06-30
Completion date2024-07-31→2025-12-31
2024-04-10
Study Status v8
Re-verified, no change to tracked fields
2023-11-20
Study Status, Outcome Measures, Contacts/Locations v7
Primary completion date2024-06-01→2024-07-31
Completion date2024-12-31→2024-07-31
Secondary endpoints8 to 7 entries
Obsessive-compulsiveBeck Depression Inventory Beliefs Conviction and Insight-II
Show 6 earlier versions
2022-12-02
Study Status, Study Design v6
PhasePhase 1→Phase 1/2
Primary completion date2023-12-31→2024-06-01
Completion date2024-06-30→2024-12-31
Start date2019-10-15→2019-10-14
Enrollment target120→100
2022-11-30
2 amendments v4-v5
2 re-verifications since 2022-05-31, no change to tracked fields
2021-01-12
Study Status, Contacts/Locations v3
Study sitescontacts updated at 1 of 1 site
2020-12-01
Study Status v2
Primary completion date2025-10-31→2023-12-31
Completion date2026-04-30→2024-06-30
2019-10-21
Study Status, Outcome Measures v1
Secondary endpoints8 entries, revised
Beliefs Conviction and Insight Experience"Not opinionJust Right" experiences and sensations in OCD
2019-10-16
Original filing
Yale University
487 trials monitored
See 35 trials at risk
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
Trial Details
NCT Number NCT04131829
Lead Sponsor Yale University
Collaborators: National Institute of Mental Health (NIMH)
Conditions Obsessive-Compulsive Disorder
Enrollment 100 participants
Start Date 2019-10-14
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-22